RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties

Elizabeth J Horn1, Amador Albor, Yuangang Liu

  • 1Department of Dermatology, Oregon Health and Science University, Portland, OR 97239, USA.

Carcinogenesis
|October 28, 2003
PubMed

Insights

Tripartite motif protein 32 (Trim32) is elevated in skin cancers and promotes cell survival by inhibiting ultraviolet B-induced apoptosis. This E3-ubiquitin ligase activity suggests a role in epidermal carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Tripartite motif protein 32 (Trim32) mRNA and protein expression is elevated in mouse models of epidermal carcinogenesis and human squamous cell carcinomas (SCCs).
  • Elevated Trim32 expression is frequently observed in experimental epidermal carcinogenesis, indicating its relevance to human cancer.
  • Trim32's role in skin cancer development and its potential as an E3-ubiquitin ligase are under investigation.

Purpose of the Study:

  • To investigate the role of Trim32 in epidermal carcinogenesis and its functional mechanisms.
  • To determine if Trim32 expression influences keratinocyte transformation, proliferation, and apoptosis.
  • To explore Trim32's E3-ubiquitin ligase activity in the context of ultraviolet B (UVB) radiation and tumor necrosis factor alpha (TNFα) signaling.

Main Methods:

  • Analysis of Trim32 mRNA and protein expression in mouse epidermal carcinogenesis models and human SCCs.
  • In vitro epidermal transformation assays and in vivo skin-grafting experiments with Trim32 transduction.
  • Assessment of apoptosis in keratinocytes and skin grafts following UVB exposure, with and without Trim32.
  • Investigation of Trim32's E3-ubiquitin ligase activity, including ubiquitylation and interaction with ubiquitylated proteins.

Main Results:

  • Transduced Trim32 increased colony formation in vitro and epidermal thickening in vivo, independent of proliferation.
  • Trim32 inhibited UVB-induced apoptosis of keratinocytes in vitro and in vivo, particularly the synergistic effect of TNFα.
  • Trim32 exhibited E3-ubiquitin ligase characteristics, including self-ubiquitylation and interaction with ubiquitylated proteins, enhanced by TNFα/UVB treatment.
  • Trim32's effects were not sufficient for tumorigenesis, even with p53 defects or phorbol ester treatment.

Conclusions:

  • Trim32 acts as an E3-ubiquitin ligase that promotes initiated cell survival in carcinogenesis by inhibiting UVB-induced TNFα apoptotic signaling.
  • Elevated Trim32 expression is a frequent event in epidermal carcinogenesis and is relevant to human skin cancer.
  • Trim32's anti-apoptotic function suggests a critical role in promoting the survival of damaged keratinocytes during UVB exposure, contributing to skin cancer development.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.